Literature DB >> 30745568

Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.

Thomas Masterson1, Premal Patel2, Ranjith Ramasamy2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30745568     DOI： 10.1038/s41443-019-0127-x

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN： 0955-9930            Impact factor:   2.896


× No keyword cloud information.
  1 in total

Review 1.  Contemporary surgical and non-surgical management of Peyronie's disease.

Authors:  George F Wayne; Billy H Cordon
Journal:  Transl Androl Urol       Date:  2018-08
  1 in total
  1 in total

Review 1.  Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.

Authors:  Sheridan M Hoy
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.